Pages that link to "Q33985182"
The following pages link to Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon (Q33985182):
Displaying 8 items.
- Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes (Q26778095) (← links)
- Formate-dependent growth and homoacetogenic fermentation by a bacterium from human feces: description of Bryantella formatexigens gen. nov., sp. nov (Q30881746) (← links)
- Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product (Q30968196) (← links)
- ZiBuPiYin recipe improves cognitive decline by regulating gut microbiota in Zucker diabetic fatty rats (Q33709405) (← links)
- Butyrate production in phylogenetically diverse Firmicutes isolated from the chicken caecum. (Q33837381) (← links)
- Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. (Q34649832) (← links)
- Formate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co-cultures of acetogenic and amylolytic human colonic bacteria (Q58555217) (← links)
- Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice. (Q64955752) (← links)